Literature DB >> 27214791

NEDD8 ultimate buster-1 regulates the abundance of TRF1 at telomeres by promoting its proteasomal degradation.

Yu Young Jeong1, Joonyoung Her1, In Kwon Chung1,2.   

Abstract

The human telomeric protein TRF1 negatively regulates telomere length by inhibiting the access of telomerase to telomeres. Here, we describe a novel function of NEDD8 ultimate buster-1 (NUB1) for regulating the levels of TRF1 at telomeres. NUB1 is a NEDD8-interacting protein, which down-regulates the NEDD8 conjugation system. We showed that NUB1 physically interacts with TRF1 and promotes its degradation by the proteasome in the absence of NEDD8 conjugation. We also demonstrated that TRF1 is conjugated to NEDD8, and that neddylated TRF1 is targeted to the proteasome for degradation in a NUB1-dependent manner. These data suggest that NUB1 participates in telomere maintenance by regulating the levels of TRF1 at telomeres through both NEDD8-dependent and NEDD8-independent pathways.
© 2016 Federation of European Biochemical Societies.

Entities:  

Keywords:  NEDD8 ultimate buster-1; neddylation; proteasome; protein degradation; telomere; telomeric repeat binding factor 1

Mesh:

Substances:

Year:  2016        PMID: 27214791     DOI: 10.1002/1873-3468.12221

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Ubiquitin-Modulated Phase Separation of Shuttle Proteins: Does Condensate Formation Promote Protein Degradation?

Authors:  Thuy P Dao; Carlos A Castañeda
Journal:  Bioessays       Date:  2020-09-03       Impact factor: 4.345

2.  MLN4924 Inhibits Defective Ribosomal Product Antigen Presentation Independently of Direct NEDDylation of Protein Antigens.

Authors:  Kartikeya Vijayasimha; Amy L Leestemaker-Palmer; James S Gibbs; Jonathan W Yewdell; Brian P Dolan
Journal:  J Immunol       Date:  2022-04-15       Impact factor: 5.426

Review 3.  The Many Potential Fates of Non-Canonical Protein Substrates Subject to NEDDylation.

Authors:  Kartikeya Vijayasimha; Brian P Dolan
Journal:  Cells       Date:  2021-10-05       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.